Induction and inhibition of CPAF activity during analysis of Chlamydia-infected cells

Pathogens and Disease

Volumn 73, Issue 1, 2015, Pages 1-8

  Johnson, Kirsten A ^a   Lee, Jennifer K ^a   Chen, Allan L ^b,c   Tan, Ming ^b   Sütterlin, Christine ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Proteolysis; Proteolytic activity; Substrates

Indexed keywords

CLASTO LACTACYSTIN; LACTACYSTIN; PROTEASE CPAF; PROTEINASE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; UREA; VIMENTIN; CLASTO-LACTACYSTIN BETA-LACTONE; CPA FACTOR; DODECYL SULFATE SODIUM; LACTONE; PROTEOME;

ANIMAL CELL; ARTICLE; CELL LYSATE; CHLAMYDIASIS; CONTROLLED STUDY; CYTOLYSIS; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; HELA CELL LINE; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; WESTERN BLOTTING; CHEMISTRY; CHLAMYDIA; CYTOLOGY; EPITHELIUM CELL; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; MICROBIOLOGY; PROCEDURES;

CHLAMYDIA; CYTOLOGICAL TECHNIQUES; ENDOPEPTIDASES; EPITHELIAL CELLS; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; LACTONES; PROTEASE INHIBITORS; PROTEOME; SODIUM DODECYL SULFATE; UREA;

EID: 84943608694     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1093/femspd/ftv007     Document Type: Article

References (13)

1. Bavoil PM, Byrne GI. Analysis of CPAF mutants: new functions, new questions (the ins and outs of a chlamydial protease). Pathog Dis 2014;71:287-91.
2. Chen AL, Johnson KA, Lee JK, et al., CPAF: a chlamydial protease in search of an authentic substrate. PLoS Pathog 2012;8:e1002842.
3. Christian J, Vier J, Paschen SA, et al., Cleavage of the NF-kappaB family protein p65/RelA by the chlamydial protease-like activity factor (CPAF) impairs proinflammatory signaling in cells infected with Chlamydiae. J Biol Chem 2010;285:41320-7.
4. Grieshaber SS, Grieshaber NA. The role of the chlamydial effector CPAF in the induction of genomic instability. Pathog Dis, 2014;72:5-6.
5. Kumar Y, Valdivia RH. Actin and intermediate filaments stabilize the Chlamydia trachomatis vacuole by forming dynamic structural scaffolds. Cell Host Microbe 2008;4:159-69.
6. Lad SP, Li J, da Silva Correia J, et al., Cleavage of p65/RelA of the NF-kappaB pathway by Chlamydia. P Natl Acad Sci USA 2007;104:2933-8.
7. Ossewaarde JM, de Vries A, Bestebroer T, et al., Application of a mycoplasma group-specific PCR for monitoring decontamination of mycoplasma-infected Chlamydia sp. strains. Appl Environ Microb 1996;62:328-31.
8. Paschen SA, Christian JG, Vier J, et al., Cytopathicity of Chlamydia is largely reproduced by expression of a single chlamydial protease. J Cell Biol 2008;182:117-27.
9. Snavely EA, Kokes M, Dunn JD, et al., Reassessing the role of the secreted protease CPAF in Chlamydia trachomatis infection through genetic approaches. Pathog Dis 2014;71:336-51.
10. Tan M, Sütterlin C. The Chlamydia protease CPAF: caution, precautions and function. Pathog Dis, 2014;72:7-9.
11. Zhong G. Killing me softly: chlamydial use of proteolysis for evading host defenses. Trends Microbiol 2009;17:467-74.
12. Zhong G, Fan P, Ji H, et al., Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 2001;193: 935-42.
13. Zhong G, Liu L, Fan T, et al., Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in Chlamydia-infected cells. J Exp Med 2000;191: 1525-34.